ASX - By Stock
|
RRL |
Re:
Under valued
|
|
Wyrm
|
1.2K |
530K |
0 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
1.2K
|
530K
|
0
|
|
ASX - By Stock
|
SRX |
Re:
Ann: Becoming a substantial holder
|
|
Wyrm
|
7 |
2.6K |
1 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
7
|
2.6K
|
1
|
|
ASX - By Stock
|
BKT |
Re:
Ann: Sydney Mining Club Investor Presentation
|
|
Wyrm
|
20 |
8.4K |
2 |
05/05/23 |
05/05/23 |
ASX - By Stock
|
20
|
8.4K
|
2
|
|
ASX - By Stock
|
QIP |
Re:
Ann: 2022 Annual Report
|
|
Wyrm
|
3 |
1.7K |
2 |
21/11/22 |
21/11/22 |
ASX - By Stock
|
3
|
1.7K
|
2
|
|
ASX - By Stock
|
TGA |
Re:
Ann: Change of Chief Financial Officer
|
|
Wyrm
|
10 |
6.3K |
1 |
05/10/22 |
05/10/22 |
ASX - By Stock
|
10
|
6.3K
|
1
|
|
ASX - By Stock
|
IHL |
Re:
Ann: IHL-216A Preclinical Study Results
|
|
Wyrm
|
43 |
20K |
5 |
10/05/22 |
10/05/22 |
ASX - By Stock
|
43
|
20K
|
5
|
|
ASX - By Stock
|
IHL |
Re:
Ann: IHL-216A Preclinical Study Results
|
|
Wyrm
|
43 |
20K |
12 |
10/05/22 |
10/05/22 |
ASX - By Stock
|
43
|
20K
|
12
|
|
ASX - By Stock
|
IHL |
Re:
Ann: IHL-216A Preclinical Study Results
|
|
Wyrm
|
43 |
20K |
2 |
10/05/22 |
10/05/22 |
ASX - By Stock
|
43
|
20K
|
2
|
|